Bailey J.E., Potokar J., Coupland N., Nutt D.J. (1995) The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man. J Psychopharmacol9: 137-142
2.
Baron B.M., Ogden A-M., Siegel B.W., Stegeman J., Ursillo R.C., Dudley M.W. (1988) Rapid downregulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine. Eur J Pharmacol154: 125-134
3.
Bolden-Watson C., Richelson E. (1993) Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci52: 1023-1029
4.
Clerc G.E., Ruimy P., Verdeau-Pailles J. (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol9: 138-143
5.
Cusack B., Nelson A., Richelson E. (1994) Binding of antidepressants to human brain receptors: focus on new generation compounds. Psychopharmacology114: 559-565
6.
Guelfi J.D., White C., Hackett D., et al. (1995) Effectiveness of venlafaxine in patients hospitalised for major depression and melancholia. J Clin Psychiatr, in press
Nelson J.C., Mazure C.M., Bowers M.B., Jatlow P.I. (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatr48: 303-307
9.
Nutt D.J., Green A.R., Grahame-Smith D.G. (1980) Enhanced 5-hydroxytryptamine and dopamine mediated behavioural responses following convulsion. I. The effects of single and repeated bicuculline-induced seizures. Neuropharmacology19: 897-900
10.
Potter W.Z., et al. (1994) The psychopharmacology of depression. Oxford University Press, Oxford.
11.
Preskorn S.H. (1994) Antidepressant drug selection: criteria and options . J Clin Psychiatr55(suppl): 6-24
12.
Seth R., Jennings A.L., Bindman J., Phillips J., Bergmann K. (1992) Combination treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression. Br J Psychiatr161: 562-565
13.
Shrivastava R.K., Cohn C., Crowder J., Davidson J., Dunner D., Feighner J., Kiev A., Patrick R. (1994) Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Pharmacol14: 322-329
14.
Thomas D.N., Nutt D.J., Holman R.B. (1992a) Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex. Br J Pharmacol106: 430-434
15.
Thomas D.N., Nutt D.J., Holman R.B. (1992b) Increased noradrenaline (NA) release after chronic but not acute sertraline administration. J Psychopharmacol7: a18
